1 – 9 of 9
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Primary screening for increased fracture risk by the FRAX® questionnaire—uptake rates in relation to invitation method
(
- Contribution to journal › Article
- 2017
-
Mark
Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women : the Malmö Diet and Cancer Study
(
- Contribution to journal › Article
- 2014
-
Mark
Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
(
- Contribution to journal › Article
- 2013
-
Mark
Low androstenedione/sex hormone binding globulin ratio increases fracture risk in postmenopausal women. The Women's Health in the Lund Area study.
(
- Contribution to journal › Article
- 2005
-
Mark
Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status A population-based study of Swedish women.
(
- Contribution to journal › Article
- 2004
-
Mark
Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1.
(
- Contribution to journal › Article
- 2003
-
Mark
Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study).
(
- Contribution to journal › Article
-
Mark
Low-dose hormone therapy and carbohydrate metabolism.
(
- Contribution to journal › Article
- 2002
-
Mark
Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17 beta-estradiol and norethisterone acetate
(
- Contribution to journal › Article